Characteristic | Value | |
---|---|---|
CMV disease | Without CMV disease | |
N = 53 (%) | N = 72 (%) | |
Risk category | ||
Men who have sex with men | 32/53 (60) | 30/72 (42) |
Intravenous drug user | 9/53 (17) | 30/72 (42) |
Other | 10/53 (19) | 11/72 (15) |
Unknown | 2/53 (4) | 1/72 (1) |
Age (median) at time of death, years | 39 | 41 |
Sex | ||
Male | 46/53 (87) | 58/72 (81) |
Female | 7/53 (13) | 14/72 (19) |
CD4 cell count* | ||
Median count, cells/mm3 | 17 | 69 |
<100 cells/mm3 | 47/53 (89) | 41/72 (57) |
<50 cells/mm3 | 43/53 (81) | 32/72 (44) |
Highly active antiretroviral therapy* | 7/53 (13) | 21/72 (29) |
Plasma HIV RNA level* | ||
Tested | 10/53 (19) | 35/72 (49) |
Median among tested, copies/mL blood | 305 000 | 35 000 |
HIV RNA < 400 copies/mL blood | 0/10 (0) | 10/35 (29) |
HIV RNA < 50 copies/mL blood | 0/10 (0) | 5/35 (14) |